Bankrupt Zosano Pharma Says Unsecured Creditors Will Recoup 28% of Claims

Dow Jones2022-08-27

Zosano Pharma Corp. says unsecured creditors owed $12.3 million in its chapter 11 bankruptcy liquidation are expected to recoup 28% of what they are owed.

The publicly traded Fremont, Calif.-based company made the disclosure Thursday in the U.S. Bankruptcy Court in Wilmington, Del.

Earlier this month, the court approved the sale of most of its assets to Emergex Vaccines.

The company, which was spun off in 2006 from a Johnson & Johnson subsidiary, struggled since the Food and Drug Administration rejected its application seeking approval for its M207 transdermal migraine patch in late 2020.

 

Write to Becky Yerak at becky.yerak@wsj.com

 

$(END)$ Dow Jones Newswires

August 26, 2022 13:26 ET (17:26 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment